CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-04 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −17,000 | 0 | ||
| 2025-07-30 | Popovits Kimberly J Director | Option exercise | +45,748 | $10.36 | $474K | 58,294 |
| 2025-07-30 | Popovits Kimberly J Director | Option exercise | +18,760 | $15.47 | $290K | 77,054 |
| 2025-07-30 | Popovits Kimberly J Director | Option exercise | −64,508 | $29.90 | $1.9M | 12,546 |
| 2025-07-30 | Popovits Kimberly J Director | Option exercise · Share Option | −45,748 | 0 | ||
| 2025-07-30 | Popovits Kimberly J Director | Option exercise · Share Option | −18,760 | 0 | ||
| 2025-07-15 | Tessari Eben CHIEF OPERATING OFFICER | Grant or award 10b5-1 | +752 | $15.63 | $12K | 49,915 |
| 2025-07-15 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award 10b5-1 | +495 | $15.63 | $8K | 33,041 |
| 2025-07-14 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +6,500 | $8.83 | $57K | 68,063 |
| 2025-07-14 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −18,900 | $28.72 | $543K | 49,163 |
| 2025-07-14 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −6,500 | 32,000 | ||
| 2025-07-01 | Levy Richard S Director | Option exercise | +1,101 | 18,474 | ||
| 2025-07-01 | Levy Richard S Director | Grant or award · Restricted Share Units | +1,101 | 1,101 | ||
| 2025-07-01 | Levy Richard S Director | Option exercise · Restricted Share Units | −1,101 | 0 | ||
| 2025-06-16 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +6,500 | $8.83 | $57K | 78,863 |
| 2025-06-16 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −17,300 | $28.28 | $489K | 61,563 |
| 2025-06-16 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −6,500 | 38,500 | ||
| 2025-06-11 | Quart Barry D Director | Option exercise | +12,336 | $3.80 | $47K | 24,882 |
| 2025-06-11 | Quart Barry D Director | Sale | −12,336 | $30.39 | $375K | 12,546 |
| 2025-06-11 | Quart Barry D Director | Option exercise · Share Option | −12,336 | 0 |
Page 29 of 74 · 1,467 trades